Skip to content

FCL Pharma

Active Risk: not assessed
Private limited companyfounded 20188 yrs activeGrotendries(LUB) 13C, 3210 Lubbeek, BelgiumKBO/BCE: BE 0688.874.501
Summary

FCL Pharma is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €474,850 and a net result of €104,960. Equity is growing by ~24.2% per year across the filed fiscal years. Its solvency ranks better than 51% of 5587 sector peers (fiscal year 2025). The company has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Outside the general model
Model not applicable to financial institutions
The Checked score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-08-2026, 30 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 8 filings
Deviation from the deadline
2025
30 d late
2024
26 d late
2023
26 d late
2022
28 d late
2021
12 d early
2020
24 d late
2019
69 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 27 days after the deadline; the sector median for financial year 2024 is 14 days before the deadline, and 28% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 27 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

FCL Pharma was incorporated on 25 January 2018.1 Total assets rose from EUR 784,771 in 2018 to EUR 895,776 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, abbreviated schema

Equity
€474,850▲ 13.1%
2024 · €419,889
Net result
€104,960▲ 14.8%
2024 · €91,465
Total assets
€895,776▲ 3.9%
2024 · €862,445
Solvency
53.0%▲ 4.3pp
2024 · 48.7%
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 64, Financial service activities, except insurance and pension funding, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€90,556▲ 21.4%€108,960▲ 20.3%€100,949▼ 7.4%€127,866▲ 26.7%€145,356▲ 13.7%
Net result€64,272within the sector's middle half▲ 26.3%€78,650above the sector's middle half▲ 22.4%€74,777within the sector's middle half▼ 4.9%€91,465within the sector's middle half▲ 22.3%€104,960within the sector's middle half▲ 14.8%
Equity€215,857within the sector's middle half▲ 42.4%€271,294within the sector's middle half▲ 25.7%€328,425within the sector's middle half▲ 21.1%€419,889within the sector's middle half▲ 27.8%€474,850within the sector's middle half▲ 13.1%
Total assets€813,879within the sector's middle half▲ 3.8%€818,386within the sector's middle half▲ 0.6%€848,364within the sector's middle half▲ 3.7%€862,445within the sector's middle half▲ 1.7%€895,776within the sector's middle half▲ 3.9%
Debt€598,022▼ 5.5%€547,091▼ 8.5%€519,940▼ 5.0%€442,556▼ 14.9%€420,927▼ 4.9%
Working capital-€50,177below the sector's middle half▲ 15.3%-€43,300below the sector's middle half▲ 13.7%-€35,293within the sector's middle half▲ 18.5%€3,702within the sector's middle half€9,479within the sector's middle half▲ 156%
Solvency26.5%within the sector's middle half▲ 7.2pp33.1%within the sector's middle half▲ 6.6pp38.7%within the sector's middle half▲ 5.6pp48.7%within the sector's middle half▲ 10.0pp53.0%within the sector's middle half▲ 4.3pp
Current ratio0.56below the sector's middle half▲ 0.160.62below the sector's middle half▲ 0.060.74within the sector's middle half▲ 0.131.03within the sector's middle half▲ 0.291.07within the sector's middle half▲ 0.03
Return on assets (ROA)7.9%within the sector's middle half▲ 1.4pp9.6%within the sector's middle half▲ 1.7pp8.8%within the sector's middle half▼ 0.8pp10.6%within the sector's middle half▲ 1.8pp11.7%within the sector's middle half▲ 1.1pp
above within below the middle half (P25 to P75) of NACE 64, Financial service activities, except insurance and pension funding, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50,000€100,000€150,000Operating result 2021: €90,556€90,556Net result 2021: €64,272€64,272Operating result 2022: €108,960€108,960Net result 2022: €78,650€78,650Operating result 2023: €100,949€100,949Net result 2023: €74,777€74,777Operating result 2024: €127,866€127,866Net result 2024: €91,465€91,465Operating result 2025: €145,356€145,356Net result 2025: €104,960€104,96020212022202320242025€0€50,000€100,000€150,000Operating result 2023: €100,949€101,000Net result 2023: €74,777€74,800Operating result 2024: €127,866€128,000Net result 2024: €91,465€91,500Operating result 2025: €145,356€145,000Net result 2025: €104,960€105,000202320242025
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 14% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €895,776
Fixed assets €745,556 ▼ 0.1%
Current assets €150,221 ▲ 29.3%
Equity and liabilities €895,776
Equity €474,850 ▲ 13.1%
Debt €420,927 ▼ 4.9%
Debt's share of the balance-sheet total falls from 51.3% to 47.0%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
ROE
22.1%▲
2024 · 21.8%
Debt ≤ 1 year
€140,741▲
2024 · €112,447
Debt > 1 year
€280,063▼
2024 · €329,943
Income taxes
€29,720▲
2024 · €25,008
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 48 lines
Balance sheet Code20242025
Assets
Total assets20/58€862,445€895,776▲
Fixed assets21/28€746,297€745,556▼
Tangible fixed assets22/27€12,912€12,171▼
Furniture and vehicles24€5,747€6,563▲
Other tangible fixed assets26€7,165€5,608▼
Financial fixed assets28€733,385€733,385=
Current assets29/58€116,149€150,221▲
Amounts receivable within one year40/41€84,535€95,620▲
Trade receivables40€74,543€95,340▲
Other amounts receivable41€9,992€280▼
Cash at bank and in hand54/58€29,813€52,702▲
Deferred charges and accrued income490/1€1,800€1,898▲
Equity and liabilities
Total equity and liabilities10/49€862,445€895,776▲
Equity10/15€419,889€474,850▲
Contributions10/11€18,600€18,600=
Reserves13€1,860€1,860=
Distributable reserves133€1,860€1,860=
Profit (loss) carried forward14€399,429€454,390▲
Amounts payable17/49€442,556€420,927▼
Amounts payable after more than one year17€329,943€280,063▼
Financial debts170/4€329,943€280,063▼
Amounts payable within one year42/48€112,447€140,741▲
Current portion of amounts payable after more than one year42€52,407€49,881▼
Financial debts43€20,000€8,333▼
Credit institutions430/8€20,000€8,333▼
Trade debts44€766€256▼
Suppliers440/4€766€256▼
Taxes, remuneration and social security45€16,074€16,571▲
Taxes450/3€14,074€14,571▲
Remuneration and social security454/9€2,000€2,000=
Other amounts payable47/48€23,200€65,700▲
Accrued charges and deferred income492/3€166€123▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2,845€3,383▲
Other operating charges640/8€630€540▼
Gross operating margin9900€131,342€149,279▲
Operating profit (loss)9901€127,866€145,356▲
Financial income75/76B€0€0▲
Recurring financial income75€0€0▲
Financial charges65/66B€11,394€10,676▼
Recurring financial charges65€11,394€10,676▼
Profit (loss) for the period before taxes9903€116,472€134,680▲
Income taxes67/77€25,008€29,720▲
Profit (loss) for the period9904€91,465€104,960▲
Profit (loss) for the period to be appropriated9905€91,465€104,960▲
Appropriation of the result
Profit (loss) to be appropriated9906€399,429€504,390▲
Profit (loss) brought forward from the previous period14P€307,965€399,429▲
Profit to be distributed694/7€0€50,000▲
Return on contributions (dividend)694€0€50,000▲

The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2,310€2,422€2,422€2,845€3,383▲ 18.9%
Other operating charges640/8€1,260€1,265€944€630€540▼ 14.2%
Gross operating margin9900€94,126€112,647€104,316€131,342€149,279▲ 13.7%
Operating profit (loss)9901€90,556€108,960€100,949€127,866€145,356▲ 13.7%
Financial income75/76B-€0€0€0€0-
Recurring financial income75-€0€0€0€0-
Financial charges65/66B€8,634€8,013€6,990€11,394€10,676▼ 6.3%
Recurring financial charges65€8,634€8,013€6,990€11,394€10,676▼ 6.3%
Profit (loss) for the period before taxes9903€81,922€100,947€93,959€116,472€134,680▲ 15.6%
Income taxes67/77€17,650€22,298€19,182€25,008€29,720▲ 18.8%
Profit (loss) for the period9904€64,272€78,650€74,777€91,465€104,960▲ 14.8%
Profit (loss) for the period to be appropriated9905€64,272€78,650€74,777€91,465€104,960▲ 14.8%
Line20212022202320242025Change
Assets
Total assets20/58€813,879€818,386€848,364€862,445€895,776▲ 3.9%
Fixed assets21/28€751,057€748,635€746,212€746,297€745,556▼ 0.1%
Tangible fixed assets22/27€17,672€15,250€12,827€12,912€12,171▼ 5.7%
Furniture and vehicles24€9,947€8,547€7,147€5,747€6,563▲ 14.2%
Other tangible fixed assets26€7,726€6,703€5,681€7,165€5,608▼ 21.7%
Financial fixed assets28€733,385€733,385€733,385€733,385€733,385=
Current assets29/58€62,822€69,751€102,152€116,149€150,221▲ 29.3%
Amounts receivable within one year40/41€15,217€57,472€40,956€84,535€95,620▲ 13.1%
Trade receivables40€15,217€57,093€40,956€74,543€95,340▲ 27.9%
Other amounts receivable41-€379-€9,992€280▼ 97.2%
Cash at bank and in hand54/58€46,511€10,998€59,401€29,813€52,702▲ 76.8%
Deferred charges and accrued income490/1€1,094€1,281€1,795€1,800€1,898▲ 5.4%
Equity and liabilities
Total equity and liabilities10/49€813,879€818,386€848,364€862,445€895,776▲ 3.9%
Equity10/15€215,857€271,294€328,425€419,889€474,850▲ 13.1%
Contributions10/11€12,400€18,600€18,600€18,600€18,600=
Reserves13€1,860€1,860€1,860€1,860€1,860=
Non-distributable reserves130/1€1,860€1,860----
Reserves not available under the articles1311€1,860€1,860----
Distributable reserves133--€1,860€1,860€1,860=
Profit (loss) carried forward14€201,597€250,834€307,965€399,429€454,390▲ 13.8%
Amounts payable17/49€598,022€547,091€519,940€442,556€420,927▼ 4.9%
Amounts payable after more than one year17€485,023€434,041€382,351€329,943€280,063▼ 15.1%
Financial debts170/4€485,023€434,041€382,351€329,943€280,063▼ 15.1%
Amounts payable within one year42/48€112,999€113,051€137,445€112,447€140,741▲ 25.2%
Current portion of amounts payable after more than one year42€50,286€50,983€54,911€52,407€49,881▼ 4.8%
Financial debts43€17,500€21,500€17,500€20,000€8,333▼ 58.3%
Credit institutions430/8€17,500€21,500€17,500€20,000€8,333▼ 58.3%
Trade debts44€165€808€235€766€256▼ 66.5%
Suppliers440/4€165€808€235€766€256▼ 66.5%
Taxes, remuneration and social security45€32,991€10,113€23,951€16,074€16,571▲ 3.1%
Taxes450/3€30,991€10,097€21,951€14,074€14,571▲ 3.5%
Remuneration and social security454/9€2,000€15€2,000€2,000€2,000=
Other amounts payable47/48€12,057€29,647€40,847€23,200€65,700▲ 183%
Accrued charges and deferred income492/3--€144€166€123▼ 26.0%
Line20212022202320242025Change
Profit (loss) for the period9904€64,272€78,650€74,777€91,465€104,960▲ 14.8%
+ Depreciation and write-downs630€2,310€2,422€2,422€2,845€3,383▲ 18.9%
Operating cash flow (approximation)€66,582€81,072€77,200€94,310€108,343▲ 14.9%
Investment in fixed assets (approximation)-€0€0-€2,930-€2,642▲ 9.8%
Change in cash--€35,513€48,403-€29,588€22,889▲ 177%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
30-08
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema · 30 days late
2025
31-12
Financial Highest result since 2018net €104,960 ▲14.8%
Operating result €145,356, net result €104,960, both a record.
26-08
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema · 26 days late
2024
26-08
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 26 days late
2023
28-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 28 days late
2022
19-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial Equity above €200,000Eq €215,857 ▲42.4%
4 profitable years in a row build equity to €215,857.
24-08
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 24 days late
2020
31-12
Financial Equity above €150,000Eq €151,584 ▲50.5%
3 profitable years in a row build equity to €151,584.
08-10
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 69 days late
2019
31-12
Financial Weakest financial yearnet €38,189 ▼23.8%
Net result drops to €38,189, the lowest in the series; recovery starts the following year.
31-12
Financial Equity above €100,000Eq €100,693 ▲61.1%
2 profitable years in a row build equity to €100,693.
23-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 23 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Lubbeek · 1 establishment unit since 2018
seat establishment The establishment unit on the map
Ground area
825 m²
Building footprint
116 m²
Volume, LiDAR
422 m³
Parcel 24066H0353/00C000, Flanders · tallest building 21.7 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
Apotheker Fien Clarysse
Grotendries(LUB) 13C, 3210 LubbeekFinancial service activities, except insurance and pension funding
since 20182.272.379.012
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24066H0353/00C000 Flanders 825 m² 1 · 116 m² 21.7 m · 1 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

1 holding

Owners 0

The accounts to 31-12-2025 list no shareholders, and no other source names one.

Holdings 1

According to the 2025 annual accounts of FCL Pharma and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Similar companies · same sector, comparable size

Of 24,729 companies in sector 64210 we hold annual accounts for 19,799. 13,652 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded25-01-2018
Fiscal year end31-12
Activities, NACEBEL 2025
64210Activities of holding companies
70100Activities of head offices
70200Business and other management consultancy
82990Other business support services
E-invoicing
Reachable via Peppol
Peppol ID 0208:0688874501
Also 9925:BE0688874501
Registered 30-01-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.